Precision treatment of beta-cell monogenic diabetes: a systematic review
Background Beta-cell monogenic forms of diabetes have strong support for precision
medicine. We systematically analyzed evidence for precision treatments for GCK-related …
medicine. We systematically analyzed evidence for precision treatments for GCK-related …
[HTML][HTML] Systematic review of treatment of beta-cell monogenic diabetes
RN Naylor, KA Patel, JLT Kettunen, JME Männistö… - medRxiv, 2023 - ncbi.nlm.nih.gov
Background: Beta-cell monogenic forms of diabetes are the area of diabetes care with the
strongest support for precision medicine. We reviewed treatment of hyperglycemia in GCK …
strongest support for precision medicine. We reviewed treatment of hyperglycemia in GCK …
A Case of 17q12 Microdeletion Syndrome in a MODY5 Type Diabetes with HNF-1β Gene Mutation Accompanied
S Zhang, Y Ma, X Zang, H Heng, X Liu… - The Application of …, 2024 - Taylor & Francis
Abstract Maturity Onset Diabetes of the Young (MODY) is an autosomal dominant inherited
disorder prevalent among adolescents. Typically, it manifests with hyperglycemia before the …
disorder prevalent among adolescents. Typically, it manifests with hyperglycemia before the …
[HTML][HTML] Maternal Transmission of 17q12 Microdeletion: Intrafamilial Phenotypic Variability and Diagnostic Hurdles—A Case Report
S Negrisolo, G Caridi, B Antoniello, E Benetti - DNA, 2024 - mdpi.com
The relatively rare proximal 17q12 microdeletion, including the deletion of the HNF1B gene,
is associated with renal cysts and diabetes syndrome (RCAD). This genomic rearrangement …
is associated with renal cysts and diabetes syndrome (RCAD). This genomic rearrangement …